Physician profile
Soonyou Kwon
NPI 1578722260
$4,266.80
in general payments reported to CMS, 2019-2025
26 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $547 · 2021: $395 · 2022: $420 · 2023: $263 · 2024: $650 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.66 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $749.16 | 2019-2025 | Tremfya |
| Abbvie INC. | $440.94 | 2019-2024 | |
| Ucb, INC. | $380.06 | 2019-2025 | Bimzelx |
| Lilly USA, LLC | $320.99 | 2019-2025 | Ebglyss, Taltz |
| Novartis Pharmaceuticals Corporation | $308.92 | 2019-2025 | |
| Pfizer INC. | $282.69 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $234.27 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $223.10 | 2019-2024 | Libtayo |
| Celgene Corporation | $193.47 | 2019 | |
| Leo Pharma INC. | $150.96 | 2020-2025 | Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $145.97 | 2019-2023 | Duobrii, Jublia, Arazlo |
| Janssen Scientific Affairs, LLC | $103.32 | 2020 | |
| Incyte Corporation | $83.73 | 2021-2025 | Opzelura |
| Amgen INC. | $82.29 | 2022 | |
| Sebela Pharmaceuticals INC. | $76.60 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $74.93 | 2019-2021 | |
| Vyne Pharmaceuticals INC. | $72.02 | 2020-2021 | |
| Genzyme Corporation | $65.19 | 2021-2022 | |
| Merz North America, INC. | $52.05 | 2019 | |
| Galderma Laboratories, L.P. | $49.57 | 2019-2020 | |
| Convatec INC. | $43.96 | 2024 | |
| Almirall LLC | $43.93 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $41.43 | 2019 | |
| Dusa Pharmaceuticals, INC. | $20.93 | 2019 | |
| Arcutis Biotherapeutics, INC. | $15.06 | 2024 | Zoryve |
| Journey Medical Corporation | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soonyou Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.